Twist Bioscience Overview

  • Founded
  • 2013
Founded
  • Status
  • Public
  • Employees
  • 652
Employees
  • Stock Symbol
  • TWST
Stock Symbol
  • Investments
  • 4
  • Share Price
  • $34.94
  • (As of Tuesday Closing)

Twist Bioscience General Information

Description

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Contact Information

Website
www.twistbioscience.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 681 Gateway Boulevard
  • South San Francisco, CA 94080
  • United States
+1 (408) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Twist Bioscience Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$34.94 $37.42 $25.88 - $139.99 $2.11B 56.3M 975K -$3.72

Twist Bioscience Financials Summary

In Thousands,
USD 		TTM 31-Mar-2022 FY 2021 30-Sep-2021 FY 2020 30-Sep-2020 FY 2019 30-Sep-2019
EV 2,541,937 4,817,120 3,119,206 624,171
Revenue 163,114 132,333 90,100 54,385
EBITDA (188,156) (144,346) (133,584) (103,004)
Net Income (187,510) (152,098) (139,931) (107,669)
Total Assets 1,021,636 702,097 398,882 186,994
Total Debt 79,662 62,921 35,982 7,733
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Twist Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Twist Bioscience‘s full profile, request access.

Request a free trial

Twist Bioscience Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore Twist Bioscience‘s full profile, request access.

Request a free trial

Twist Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize t
Drug Discovery
South San Francisco, CA
652 As of 2021
00000
00000000 00000

00000 00

na aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
000000000 00000 (0000000000)
San Diego, CA
000 As of 0000
00000
0000 0000-00-00
00000000 00000

00000000

strud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
0000 000000000
Menlo Park, CA
000 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Twist Bioscience Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Codex DNA Formerly VC-backed San Diego, CA 000 00000 00000000 00000
0000000000 Formerly VC-backed Menlo Park, CA 000 00000 00000000 00000
000000000 00000000 Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
0000000 Venture Capital-Backed Cambridge, United Kingdom 00 000.00 00000000000 000.00
00000000 Formerly VC-backed San Diego, CA 00000 00000 000000&0
You’re viewing 5 of 24 competitors. Get the full list »

Twist Bioscience Patents

  • 193

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 11

    Granted

  • 18

    Pending

  • 000

    Expiring in next 12 mo

Twist Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210355194-A1 Variant nucleic acid libraries for coronavirus Pending 27-Apr-2020 000000000
US-20210179724-A1 Variant nucleic acid libraries for adenosine receptors Pending 09-Dec-2019 000000000
US-20210102192-A1 Variant nucleic acid libraries for crth2 Pending 23-Sep-2019 000000000
US-20210102195-A1 Variant nucleic acid libraries for single domain antibodies Pending 23-Sep-2019 00000000000
US-20210071168-A1 Barcode-based nucleic acid sequence assembly Pending 21-Jun-2019 C12N9/1241
To view Twist Bioscience’s complete patent history, request access »

Twist Bioscience Executive Team (19)

Name Title Board Seat Contact Info
Emily Leproust Ph.D Chief Executive Officer & Chairman
James Thorburn Chief Financial Officer
Siyuan Chen Ph.D Chief Technology Officer
Kevin Yankton Chief Accounting Officer, Accounting
Aaron Sato Ph.D Chief Scientific Officer & Vice President, Protein Engineering
You’re viewing 5 of 19 executive team members. Get the full list »

Twist Bioscience Board Members (19)

Name Representing Role Since
Emily Leproust Ph.D Twist Bioscience Chief Executive Officer & Chairman 000 0000
Frederick Craves Ph.D Self Board Member 000 0000
Jan Johannessen Twist Bioscience Board Member 000 0000
Keith Crandell ARCH Venture Partners Board Member 000 0000
Melissa Starovasnik Twist Bioscience Board Member 000 0000
You’re viewing 5 of 19 board members. Get the full list »

Twist Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Twist Bioscience Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Twist Bioscience‘s full profile, request access.

Request a free trial

Twist Bioscience Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 01-Dec-2021 0000000000 00000 Drug Discovery 00000 000
0000000 00000 01-Nov-2021 000000000 000.00 Biotechnology 00000 000
0000000 14-Jun-2021 0000000000 000.00 Other Healthcare Technology Systems 00000 000
Genome Compiler 07-Apr-2016 Merger/Acquisition 00.00 Biotechnology 00000 000
To view Twist Bioscience’s complete investments and acquisitions history, request access »

Twist Bioscience Subsidiaries (3)

Company Name Industry Location Founded
Abveris Drug Discovery Quincy, MA 2017
0000000 Other Healthcare Technology Systems San Francisco, CA 0000
000000 00000000 Biotechnology Los Altos, CA 0000
To view Twist Bioscience’s complete subsidiaries history, request access »